Live Breaking News & Updates on Gupta Strategists

With pharmaceutical regulation currently under review across Europe, Maarten Meulenbelt, Partner at Sidley Austin LLP, discusses some of the more controversial amendments under consideration. ....

United Kingdom , Bruxelles Capitale , City Of , Noord Holland , The Council , Hannah Balfour , Maarten Meulenbelt , Dolon Ltd , Sidley Austin , Eu Pharmaceuticals Strategy , European Parliament , European Commission , Office Of Health Economics , European Federation Of Pharmaceutical Industry Associations , Partner At Sidley Austin , United Kingdom Office Of Health Economics , European Union , European Medicines Agency Text , European Pharmaceutical Review , Member States , Net Present Value , Health Economics , European Federation , Pharmaceutical Industry Associations , Orphan Drug Regulation , Orphan Drug ,